Phyllis Barkman Ferrell
Phyllis Ferrell and her team are responsible for Marketing and Operations worldwide. Previously Phyllis was Vice President of the Global Alzheimer’s disease team, where she and her team were responsible for the late-development and global registration of solanezumab, Amyvid and lanabecestat, including global launches and commercialization.
Phyllis received an MBA in general management and a certificate in public management from Stanford University where she graduated with Arjay Miller Scholar honors and was the Arbuckle Award recipient. Phyllis was recognized with the Rising Star Award from the Healthcare Businesswomen’s Association and is a member of the World Dementia Council. She is also on the Boards of Directors for the Indiana Chapter of the Alzheimer’s Association and the Stanford Associate Board of Governors; a founding member of Women Against Alzheimer’s; and a wife and mother of two very active boys (ages 16 and 12).